Overview

Continuation of Drug Supply in Chinese Patients After CAMN107DBR01study Termination

Status:
No longer available
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Continuation of drug supply in Chinese patients after CAMN107DBR01study termination.
Details
Lead Sponsor:
Novartis Pharmaceuticals
Treatments:
Imatinib Mesylate